SCHEMBL17409351

SCHEMBL17409351

O=C1NCCCN1[C@H]1C[C@H](OCc2ccccc2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.40
CTSL P07711 2/20 0.40
CTSB P07858 2/20 0.40
CTSK P43235 2/20 0.40
TMEM97 Q5BJF2 1/20 0.38
CARM1 Q86X55 1/20 0.38
PRMT6 Q96LA8 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
PRMT8 Q9NR22 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
AGTR2 P50052 2/20 0.37
CTSV O60911 1/20 0.36
CTSS P25774 1/20 0.36
CTSC P53634 1/20 0.36
CTSF Q9UBX1 1/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
KCNH2 Q12809 1/20 0.36
GAA P10253 1/20 0.36
GRIN2D O15399 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17395977 0.92 CYP2C19 (0.42) CYP2C19CTSLCTSBCTSKTMEM97
SCHEMBL17395976 0.92 CYP2C19 (0.42) CYP2C19CTSLCTSBCTSKTMEM97
SCHEMBL2857739 0.74 SMN1; SMN2 (0.58) CYP2C19GRIN2B
SCHEMBL38659290 0.73 SLC6A2 (0.44) CYP2C19CTSLCTSBCTSKTMEM97
SCHEMBL22528421 0.73 TSHR (0.45) GAA
SCHEMBL11217794 0.73 OPRL1 (0.57) CYP2C19DRD2DRD3
SCHEMBL20986826 0.72 SMN1; SMN2 (0.49) CYP2C19TMEM97SIGMAR1HRH3DRD3
SCHEMBL23583709 0.70 CTSL (0.53) CYP2C19CTSLCTSBCTSKTMEM97
SCHEMBL1988191 0.70 CTSL (0.53) CYP2C19CTSLCTSBCTSKTMEM97
SCHEMBL1438982 0.70 CTSL (0.53) CYP2C19CTSLCTSBCTSKTMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016001789-A1 PYRIMIDINE DERIVATIVES AS PI3K INHIBITORS FOR USE IN THE TREATMENT OF CANCER PFIZER INC. (US) 2016-01-07 WO disclosed